<div id="readability-page-1"><p>Maxim Group analyst Naz Rahman reiterated a Buy rating on NexGel Inc yesterday and set a price target of $6.00. The company’s shares closed yesterday at $2.02.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Rahman covers the Healthcare sector, focusing on stocks such as Vivani Medical, Kazia Therapeutics, and Silexion Therapeutics. According to TipRanks, Rahman has an average return of <span>-9.3%</span> and a 33.33% success rate on recommended stocks. </p> <p>NexGel Inc has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.</p></div>

NXGL

<p>Maxim Group analyst Naz Rahman reiterated a Buy rating on NexGel Inc, setting a price target of $6.00. The stock closed at $2.02. Rahman, who covers the Healthcare sector, has an average return of -9.3% and a 33.33% success rate. NexGel Inc has a Moderate Buy consensus with a $6.00 price target.</p>

Maxim Group Keeps Their Buy Rating on NexGel Inc (NXGL)